Organogenesis
ORGO
$2.35
Share price
2.84%
Change (1 day)
14.63%
Change (1 year)
Categories
Organogenesis (ORGO) - Net assets
Net assets on the balance sheet as of December 2023 : $0.27 B
According to Organogenesis's latest financial reports the company has $0.27 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Organogenesis - Net assets on balance sheet (from 2016 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | 4.89% |
| 2022-12-31 | $0.26 B | 10.08% |
| 2021-12-31 | $0.24 B | 70.18% |
| 2020-12-31 | $0.14 B | 155.13% |
| 2019-12-31 | $55.58 M | 18.16% |
| 2018-12-31 | $47.04 M | -649.87% |
| 2017-12-31 | $-8.56 M | -102.85% |
| 2016-12-31 | $0.30 B | -185251674.69% |
| 2015-12-31 | $-0.01 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.38 B | 398.53% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $10.67 M | -96.17% | 🇺🇸 USA |